COSCIENS Biopharma Inc T.CSCI

Cosciens Biopharm Partners Complete Oat Care Program:

[prophetoffactz]

Consciens Biopharma partners with Dr. Li for its Complete Oat Care program as the sweet spot of early intervention gains traction?

Perplexity Ai:

The recent discussion around extending the risk period for cardiovascular disease (CVD) beyond 10 years is gaining traction, particularly in light of emerging evidence supporting early intervention strategies. This approach emphasizes the importance of addressing key factors such as inflammation, low-density lipoprotein (LDL) cholesterol, and Lipoprotein(a) to mitigate long-term cardiovascular risks.

Key Insights from Recent Research

1. Extended Risk Period: The suggestion to extend the cardiovascular risk assessment period beyond the traditional 10 years aligns with findings that indicate significant long-term cardiovascular outcomes are influenced by factors present well before the onset of clinical symptoms. Research has shown that conditions like inflammation and elevated cholesterol levels can contribute to the development of CVD over decades, necessitating a broader timeframe for risk assessment and intervention.
2. Nutraceutical Interventions: The discussion also highlights the potential of nutraceuticals, such as those offered by Cosciens Biopharma. Their products include:
   • Pharma-grade avenanthramide pills: These are compounds derived from oats that may help reduce inflammation.
   • Beta-glucan and avenanthramide chewy bars: These snacks are designed to support heart health through their beneficial components.
   • CoQ10: Known for its role in cellular energy production, CoQ10 may also have cardiovascular benefits.
   • Avenanthramide oat flour: This ingredient can be incorporated into various recipes to promote heart health.
3. Systemic Inflammation Control: The use of topical products like Juvente, which is applied to the skin, is suggested as a means to manage systemic inflammation. This aligns with the understanding that controlling inflammation is crucial for preventing cardiovascular diseases.

Conclusion

The call for an extended risk period for cardiovascular disease reflects a growing recognition of the complex interplay between inflammation, cholesterol levels, and long-term cardiovascular health. Early interventions, including lifestyle changes and the use of nutraceuticals, could play a pivotal role in managing these risks effectively. As research continues to evolve, it will be essential to integrate these findings into clinical practice to enhance prevention strategies for cardiovascular diseases.

[prophetoffactz]

Drugs are late-stage disease interventions. Changing lifestyles and neutraceuticals are the emerging sweet spot for preventing disease. There has been a recent high profile call in the US to 'Make America Healthy Again' given the crippling burden of chronic and lifestyle disease. Consciens Biophama is well positioned to play a role. If Trump wins maybe a promotion with the controversial